甲基与甲基相比,以及内血管血栓切除术中的第一通透再输血
William K Diprose1,2, Fouzi Bala1,3, Bijoy K Menon1,4
1From the Department of Clinical Neurosciences(W.K.D., F.B., B.K.M., N.S., M.H., T.S., M.D.H., M.A.), Cumming School of Medicine, University of Calgary, Calgary, Canada.
AJNR. American journal of neuroradiology
|August 1, 2025
概括
在静脉内血栓切除术之前,选择静脉注射的丁氏甲和高氏甲之间,不会影响急性缺血性中风患者的第一通再输血的可能性. 这项研究发现,这两种血栓溶解剂之间的再输血率没有显著差异.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 干预性放射学 干预性放射学
背景情况:
- 内血管血栓切除术 (EVT) 是急性缺血性中风的关键治疗方法.
- 在EVT之前选择静脉血栓解毒剂,特别是tenecteplase与alteplase,正在研究其对再输血结果的影响.
- 第一次通过再输血是EVT的关键早期结果.
研究的目的:
- 为了比较静脉注射 tenecteplase 与 alteplase 在急性缺血性中风中在 EVT 期间实现第一通复注的疗效.
- 评估血栓解毒剂选择对重灌重点指标的影响.
主要方法:
- 在患有急性缺血性中风 (AcT) 患者中,对阿尔特等相比与特内克等试验的数据分析.
- 包括445名接受EVT的患者,并比较了那些接受静脉 Tenecteplase (n=226) 和IV Alteplase (n=219) 的人之间的结果.
- 主要结局:第一通再注血 (eTICI 2c-3单通);次要结局:修改的第一通再注血,最终的再注血分数,通过次数和再注血的时间.
主要成果:
- 第一次通过再注血在基基组的35.0%和高基基组的41.1% (P=.20) 中实现了.
- 修改的第一通再输率是相似的:54.4%的甲和55.7%的高甲 (P=.85).
- 两组之间在最终的再输血得分,输血次数或再输血的时间上没有显著差异.
结论:
- 选择静脉血栓抑制剂 (tenecteplase或alteplase) 并没有显著影响在接受EVT的患者中实现第一通复注的概率.
- 这些发现表明,目前的血栓解毒选择不会对EVT手术中早期再输血的成功产生差异性影响.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
01:16Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K